USANA HEALTH SCIENCES INC — Form 10-Q/A
Filed November 19, 2026 · analyzed by the Periodic Agent
10-Q/A
— Neutral
significance 12/100
What the filing says
USANA filed Amendment No. 1 to its Q2 2026 10-Q (quarter ended October 3, 2026) on November 19, 2026. CEO Kevin G. Guest and CFO G. Douglas Hekking certified the amended report's compliance with SEC rules and accuracy of financial statements and disclosure controls. The filing contains only standard Sarbanes-Oxley certification exhibits; no specific financial restatements, corrected amounts, or material changes are disclosed in this excerpt.
Why this rating
10-Q/A amendment with no disclosed material changes; routine administrative restatement or correction process unspecified here.
See more from November 19, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.